Delivery Order SPE2DR25D1051-SPE2DR26F38F9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,124.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $12,796.26 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injectors on November 24, 2025, with an ultimate completion date of November 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,886.71 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on December 3, 2025, with an ultimate completion date of December 4, 2025. This non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,518.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order executed under an existing contract vehicle and requires fulfillment within an...
- The Defense Logistics Agency awarded a $72,385.69 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injections on December 9, 2025. This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. The delivery order represents a single transaction under AmerisourceBergen's larger federal contract vehicle with DLA Troop Support Medical. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,364.41 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,561.48 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injectors on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed price delivery order, which carries no set-aside designation, is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $2,807.37 delivery order to AmerisourceBergen Drug Corp for supply of Zepbound 7.5 mg/0.5 mL pen injectors, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child purchase order under a larger contract vehicle supporting federal pharmaceutical...
- The Defense Logistics Agency awarded a $9,848.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. The contract, which is not set-aside, has an ultimate completion date of December 8, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 18, 2025, for Zepbound 7.5 mg/0.5 mL pen injections with a ceiling value of $1,134.73. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with ultimate completion scheduled for November 19, 2025. The order will be fulfilled at AmerisourceBergen's Conshohocken facility...
- SPE2DR25D1051Indefinite Delivery Contract
- SPE2DR25D1051-SPE2DR26F38F9Delivery Order
The Defense Logistics Agency awarded a $6,801.60 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child delivery order under the company's larger indefinite delivery contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive pharmaceutical supply portfolio. This delivery order falls under the company's existing $999.999 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and supports military healthcare programs globally. The underlying vehicle enables AmerisourceBergen to supply specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. No set-aside was utilized for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 12/3/25 |